Moore Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30,000
| Closed | -$675K | – | 559 |
|
|
2023
Q1 | $675K | Buy |
+30,000
| New | +$675K | 0.01% | 283 |
|
|
2022
Q4 | – | Sell |
-191,724
| Closed | -$4.72M | – | 625 |
|
|
2022
Q3 | $4.72M | Buy |
191,724
+105,688
| +123% | +$2.6M | 0.11% | 192 |
|
|
2022
Q2 | $2.09M | Buy |
86,036
+63,093
| +275% | +$1.53M | 0.06% | 307 |
|
|
2022
Q1 | $591K | Buy |
+22,943
| New | +$591K | 0.02% | 435 |
|
|
2015
Q3 | – | Sell |
-85,000
| Closed | -$2.82M | – | 366 |
|
|
2015
Q2 | $2.82M | Buy |
+85,000
| New | +$2.82M | 0.06% | 223 |
|